Provided by Tiger Fintech (Singapore) Pte. Ltd.

Option Care Health Inc

31.56
-0.2800-0.88%
Post-market: 31.560.00000.00%16:39 EDT
Volume:2.73M
Turnover:86.41M
Market Cap:5.17B
PE:25.21
High:32.01
Open:31.83
Low:31.27
Close:31.84
Loading ...

Option Care Health Is Maintained at Overweight by JP Morgan

Dow Jones
·
07 Mar

3 Highly Ranked Medical Stocks to Buy Amid Recent Market Volatility: JAZZ, OPCH, PCRX,

Zacks
·
06 Mar

Teladoc Health Enhances Prism Platform for Better Virtual Care

Zacks
·
06 Mar

BrightSpring Health Services (BTSG) Q4 Earnings: What To Expect

StockStory
·
05 Mar

It's Not Time To Buy. But These Stocks Flash 'Watch Me' Signs.

Blockhead
·
05 Mar

S&P 500 Futures Up In Premarket Trading; Option Care Health, Independence Realty Trust Lag

Dow Jones
·
05 Mar

Earnings Estimates Rising for Option Care (OPCH): Will It Gain?

Zacks
·
05 Mar

OPCH or CHE: Which Is the Better Value Stock Right Now?

Zacks
·
05 Mar

Best Momentum Stocks to Buy for March 4th

Zacks
·
04 Mar

Option Care Health, Inc. (OPCH) Hit a 52 Week High, Can the Run Continue?

Zacks
·
04 Mar

Trade Alert: Chief Human Resources & Chief Diversity Officer Of Option Care Health Michael Bavaro Has Sold Stock

Simply Wall St.
·
04 Mar

New Strong Buy Stocks for March 4th

Zacks
·
04 Mar

After Golden Cross, Option Care (OPCH)'s Technical Outlook is Bright

Zacks
·
28 Feb

Option Care Health Is Maintained at Outperform by Barrington Research

Dow Jones
·
27 Feb

Deutsche Bank Adjusts Option Care Health Price Target to $39 From $30, Maintains Buy Rating

MT Newswires Live
·
27 Feb

Option Care Health Inc : Barrington Research Raises Target Price to $38 From $33

THOMSON REUTERS
·
27 Feb

Option Care Health Full Year 2024 Earnings: Beats Expectations

Simply Wall St.
·
27 Feb

Option Care Health Inc (OPCH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

GuruFocus.com
·
27 Feb

JMP Securities Sticks to Their Buy Rating for Option Care Health (OPCH)

TIPRANKS
·
27 Feb

BUZZ-U.S. STOCKS ON THE MOVE-Cheesecake Factory, SiriusPoint, Arcutis Biosciences

Reuters
·
27 Feb